Press Releases Events & Presentations Press Releases Year None2019201820172016201520142013201220112010 Nov 18, 2019 Assembly Biosciences Announces Presentation at Jefferies London Healthcare Conference View HTML PDF Version Nov 11, 2019 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019 View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Nov 07, 2019 Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer View HTML PDF Version Oct 28, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Oct 28, 2019 Assembly Biosciences Appoints Thomas J. Russo as Chief Financial Officer View HTML PDF Version Oct 16, 2019 Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD View HTML PDF Version Aug 09, 2019 Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Aug 07, 2019 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None2019201820172016201520142013201220112010 Nov 18, 2019 Assembly Biosciences Announces Presentation at Jefferies London Healthcare Conference View HTML PDF Version Nov 11, 2019 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019 View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Nov 07, 2019 Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Nov 07, 2019 Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer View HTML PDF Version Oct 28, 2019 Assembly Biosciences Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Oct 28, 2019 Assembly Biosciences Appoints Thomas J. Russo as Chief Financial Officer View HTML PDF Version Oct 16, 2019 Safety and Antiviral Activity of Assembly Biosciences’ First and Second Generation Core Inhibitor Candidates In the Treatment of Chronic Hepatitis B to be Featured in a Late Breaking Session at AASLD View HTML PDF Version Aug 09, 2019 Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Aug 07, 2019 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
